National Vision Corp - Gedhene kewajiban jangka dawa EYE

Logo grafis America's Best Contacts & Eyeglasses (EYE)

National Vision Holdings (EYE) demonstrates stability in its long-term liabilities due to import diversification through central hubs. The level of 0.57 represents the current value of this metric. The business relies on fundamental demand for vision correction, which reduces cyclical dependency; however, trade disputes with China and disruptions in maritime shipping are weighing on the margins of frame supplies.

EYE Utang jangka dawa perusahaan National Vision Corp (04.07.2022 - 01.11.2026)
Barang unggulan National Vision Holdings, Inc.

An analysis of long-term liabilities allows for an assessment of the issuer's financial stability through credit load dynamics, where a reduction in debt according to the business's long-term borrowed capital schedule signals a strengthening balance sheet. For National Vision Holdings (EYE), such debt optimization, supported by stable traffic from Walmart and insurance partners, minimizes retail risks and ensures the secure development of its diversified brand network.

Karo sapa National Vision Holdings saingan

Utang jangka dawa perusahaan HCA Inc. HCA|THC: Kewajiban jangka dawa perusahaan|Fresenius Medical Care AG - Gedhene kewajiban jangka dawa|Solventum Inc. (SOLV) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Encompass|UHS (Universal Health Services Inc) - Utang jangka dawa perusahaan|Utang jangka dawa davita.com DVA|Utang jangka dawa perusahaan RadNet (RDNT)|Option Care - Tanggungan utang jangka dawa perusahaan|Surgery Partners Corp - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka dawa PINC (Premier Health)|PGNY - Utang jangka dawa perusahaan|ARDT (ardenthealth.com) - Tanggungan utang jangka dawa perusahaan|SEM: Utang jangka dawa perusahaan|Astrana Health Inc (ASTH) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan MD|USPH (US Physical Therapy Inc) - Gedhene kewajiban jangka dawa|Utang jangka dawa perusahaan PNTG|Gunggunge utang jangka dawa organogenesis.com|Utang jangka dawa perusahaan Nutex Health NUTX|Auna S.A. (AUNA) - Utang jangka dawa|SBC - Utang jangka dawa perusahaan|EOLS (Evolus Corp) - Tanggungan utang jangka dawa perusahaan|CYH: Utang jangka dawa perusahaan|BeautyHealth (SKIN) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan MediWound Ltd|Utang jangka dawa perusahaan BTMD|Kewajiban jangka dawa perusahaan JYNT (The Joint Corporation)|DCGO (DocGo, Inc) - Silihan lan utang jangka dawa perusahaan|P3 Health Partners - Kewajiban jangka dawa perusahaan|Gain Therapeutics Inc. - Utang jangka dawa perusahaan|EUDA Health - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa Basel Medical Group BMGL|collplant.com (CLGN) - Utang jangka dawa perusahaan|CUPR - Gunggunge utang jangka dawa|CCM (Concord Medical Services) - Utang jangka dawa perusahaan|ashs.com (AMS) - Gunggunge utang jangka dawa|Utang jangka dawa perusahaan MEDIROM Healthcare Group (MRM)|ALBT - Utang jangka dawa|Utang jangka dawa perusahaan DIH Holding US Inc. DHAI|XAGE: Tanggungan utang jangka dawa perusahaan|NIVF: Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan ATIP (ATI Physical Therapy)|CMAX: Utang jangka dawa perusahaan|Kindly MD Inc - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan LogistiCare|Utang jangka dawa Novo Integrated Sciences Corp NVOS|Utang jangka dawa perusahaan SunLink Health Systems (SSY)|Utang jangka dawa perusahaan BACK (imacholdings.comm)